US HIFU, LLC is a privately held healthcare company focused on treating primary and recurrent prostate cancer using HIFU, a minimally invasive outpatient procedure which significantly improves patients’ quality of life. US HIFU was founded in 2004 and is headquartered in Charlotte, N.C.

US HIFU is the parent company of:

o International HIFU—The entity through which US HIFU conducts its international business operations and makes HIFU technologies available to patients outside the United States.

o Focus Surgery, Inc.—headquartered in Indianapolis, Ind., Focus Surgery is the developer and manufacturer of the Sonablate® 500, a medical device that uses HIFU energy to treat prostate cancer.

o US HIFU, LLC is funding FDA-approved U.S. clinical trials of the Sonablate® 500, including a trial for primary prostate cancer patients and a trial for patients who have experienced radiation failure.


Disclaimer: The Sonablate 500 is under investigation and is not approved for use in the US. Please see the complete information in our Disclaimer page